Postprocedural clinical outcomes by genotype groupsa
| Group 1 (n = 44) | Group 2 (n = 31) | Group 3 (n = 28) | Group 4 (n = 5) | Fisher Exact Test, P Value | |
|---|---|---|---|---|---|
| Ischemic complication (No.) (%) | 5 (11.4) | 3 (9.7) | 9 (32.1) | 1 (20.0) | .08 |
| Hemorrhagic complication (No.) (%) | 8 (18.2) | 1 (3.2) | 5 (17.9) | 2 (40.0) | .06 |
| mRS ≥2 (No.) (%) | 5 (11.4) | 1 (3.2) | 2 (7.1) | 1 (20.0) | .35 |
↵a Group 1: CYP2C19*1/*1; Group 2: CYP2C19*1/*2,*1/*3, *2/*2, *2/*3; Group 3: CYP2C19*1/*17,*17/*17; Group 4: CYP2C19*2/*17.